Genetic Variants Associated with Cancer Pain and Response to Opioid Analgesics: Implications for Precision Pain Management
Related Experiment Video
Updated: Jan 25, 2026

Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
Published on: November 15, 2024
Gee Su Yang1, Natalie M Barnes1, Debra E Lyon1
1University of Florida College of Nursing, Gainesville, FL.
Objective:
To review the current knowledge on the association of genetic variants with cancer pain.
Data Sources:
Data-based publications and review articles retrieved from PubMed, CINAHL, and Web of Science, as well as an additional search in Google Scholar.
Conclusion:
Genetic variability can influence differential pain perception and response to opioids in cancer patients, which will have implications in the optimal personalized treatment of cancer pain. More studies are warranted to replicate findings.
Implications For Nursing Practice:
Nurses are poised to educate patients on biomarker testing and interpretation and to use precision pain management strategies based on this information.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Pain
Primary Motives: Sleep, Sex, and Pain Avoidance
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...
Opioid Receptors: Overview

